RXO - Company ID 0001929561
The table below shows RXO, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | $1.43B | $1.42B | $1.42B | $1.43B | $1.04B | $930.00M |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - |
| SG&A |
RXO, Inc. reported annual revenue of $5.74B for fiscal year 2025. That is up 26.2% from $4.55B in fiscal 2024. Over the 6 fiscal years shown, annual revenue grew from $3.36B (FY 2020) to $5.74B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $197.00M |
| $208.00M |
| $214.00M |
| $210.00M |
| $149.00M |
| $154.00M |
| Operating income | -$28.00M | -$7.00M | $0.00 | -$30.00M | -$20.00M | $0.00 |
| Income tax | -$13.00M | -$1.00M | -$1.00M | -$8.00M | $1.00M | -$1.00M |
| Net income | -$36.00M | -$14.00M | -$9.00M | -$31.00M | -$243.00M | -$7.00M |
| EPS (diluted) | -$0.21 | -$0.08 | -$0.05 | -$0.18 | -$1.81 | -$0.06 |